Alembic Pharma receives EIR for API Facility at Karakhadi

17 Mar 2020 Evaluate

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out by them at its API Facility at Karakhadi during the period from January 13, 2020 to January 17, 2020.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

839.00 -13.30 (-1.56%)
29-Dec-2025 12:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.00
Dr. Reddys Lab 1266.60
Cipla 1499.10
Zydus Lifesciences 903.15
Lupin 2095.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×